Navigation Links
Amicus Therapeutics Adds Sol J. Barer, Ph.D. to Board of Directors
Date:1/8/2009

CRANBURY, N.J., Jan. 8 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD) today announced the election of Sol J. Barer, Ph.D., to its Board of Directors. Dr. Barer currently serves as Chairman and Chief Executive Officer of Celgene Corporation. As an industry veteran, Dr. Barer brings over 20 years of management experience and a reputation as a trusted and respected leader who has helped transform Celgene into one of the world's preeminent biopharmaceutical companies.

John F. Crowley, President and CEO of Amicus Therapeutics stated, "2009 will be an important year for the Company as we leverage our chaperone technology and continue to advance our three lead drug candidates for Fabry, Gaucher and Pompe diseases. We look forward to Dr. Barer's leadership and guidance as Amicus continues along the path of development and commercialization for new, oral treatments for a range of human genetic diseases. We welcome him to our Board."

Separately, Amicus announced today that Gregory M. Weinhoff has chosen to resign from the Board of Directors effective January 7, 2009.

About Sol. J. Barer, Ph.D.

Dr. Barer has been Chief Executive Officer of Celgene Corporation since May 1, 2006, and Chairman since January 1, 2007. He was appointed President of Celgene in 1993, Chief Operating Officer and Director in 1994 and is a member of the Executive Committee of the Board of Directors. He previously served as Senior Vice President, Science and Technology, and Vice President/ General Manager, Chiral Products, from 1991 to 1994, and the Vice President, Technology, from 1987 to 1991. Dr. Barer is on the Board of Trustees of Rutgers University, Board of Directors of PhRMA, serves on the Board of Trustees of the Biotechnology Council of New Jersey and is on the Board of the Brooklyn College'/>"/>

SOURCE Amicus Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Amicus Therapeutics to Present at Lazard Capital Markets Healthcare Conference
2. Amicus Therapeutics Announces Third Quarter 2008 Financial Results
3. Amicus Therapeutics Announces Third Quarter 2008 Results Release Date
4. Amicus Therapeutics to Present at the 2008 UBS Global Life Sciences Conference
5. Amicus Therapeutics Opens Research Facility in San Diego
6. Amicus Therapeutics to Present at the 2008 BioCentury NewsMakers in the Biotech Industry Conference
7. Amicus Therapeutics Announces Second Quarter 2008 Results Release Date
8. Amicus Therapeutics Announces First Quarter 2008 Financial Results
9. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference
10. Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease
11. Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... Z Trim Holdings, Inc. (OTC Markets: ... ingredients to a variety of industries, today announced ... application at this year,s annual Institute of Food ... , July 13-16. The Company will demonstrate how ... in meat products thereby helping manufacturers lower costs ...
(Date:6/17/2013)... , June 17, 2013 ... ) has announced the addition of the ... - by Formulations [Liposomes, Microspheres, & Nanoparticles], ... Pen, Needle Free & Auto Injectors] & ... their offering. ,      (Logo: ...
(Date:6/17/2013)... As interest increases in developing novel biomarker ... the need to keep up with the pace of ... the first in a series titled “Better Methods for ... a range of technologies, introduces a novel method for ... proteins than either ELISA or traditional LCMS can achieve. ...
(Date:6/17/2013)... VARTA Microbattery, the ... the opening of its new North American Headquarters ... business community received an inside look at the ... powered the camera Neil Armstrong used to capture ... showcasing VARTA’s many historic achievements and innovative new ...
Breaking Biology Technology:Z Trim to Spotlight New Meat Applications at IFT 2013 in Chicago 2Z Trim to Spotlight New Meat Applications at IFT 2013 in Chicago 3North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017 2North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017 3Quantitative Analysis of Biomarkers, New Life Science Webinar Hosted by Xtalks 2VARTA Microbattery Celebrates New North American Headquarters in Rye, NY 2VARTA Microbattery Celebrates New North American Headquarters in Rye, NY 3VARTA Microbattery Celebrates New North American Headquarters in Rye, NY 4
... ... its Board of Directors. , ... Alachua, FL (PRWEB) September 16, 2009 -- NovaMin Technology Inc. (NTI) announced ... is President and CEO of Columbia Biosciences Corporation which he founded in 2007 to ...
... Pa., Sept. 16 Kensey Nash Corporation (Nasdaq: KNSY ... Sciences conference at the Grand Hyatt New York in New York ... Joseph W. Kaufmann, Kensey Nash,s President & CEO, will deliver the ... the live webcast of the Kensey Nash presentation at the UBS ...
... , SAN MARINO, Calif., Sept. ... at biotechnology company Viral Genetics (Pink Sheets: VRAL), will address ... presentation entitled: "The Impact of Custom Peptides on Chronic Inflammation," ... conference is being held at The Loews Santa Monica Beach ...
Cached Biology Technology:NovaMin Technology Inc. Welcomes New Board Member 2Viral Genetics' Lead Scientist Dr. M. Karen Newell Will Present at 11th Annual SoCalBio Investor and Partnership Conference 2
(Date:6/16/2013)... cells use to group together and move around the body ... the first time by scientists at UCL. , Published ... on the process that occurs when cancer cells interact with ... metastasis. Scientists know that cancer cells recruit healthy cells and ... takes place and how it could be controlled to design ...
(Date:6/14/2013)... Many students have difficulty understanding and explaining how ... teach the subject, researchers at Michigan State University ... from the molecular changes underlying an evolving characteristic ... The researchers, Peter J. T. White, Merle K. ... of the scenarios into a cellular and molecular ...
(Date:6/14/2013)... warms up Wisconsin, humans aren,t the only ones tending ... of Bacteriology, colonies of leaf-cutter ants cultivate thriving communities ... , While these fungus gardens are a source of ... are potential models for better biofuel production. , "We ... a lot of plant biomass goes in and is ...
Breaking Biology News(10 mins):'Chase and run' cell movement mechanism explains process of metastasis 2Teaching complete evolutionary stories increases learning 2Researchers unearth bioenergy potential in leaf-cutter ant communities 2Researchers unearth bioenergy potential in leaf-cutter ant communities 3
... widely known that the brain perceives information before it reaches ... to determine what specific mental tasks were taking place prior ... with the findings of scientists at Rutgers University in Newark ... a highly accurate way to peer into the brain to ...
... Rabalais, Ph.D., from the Louisiana Universities Marine Consortium (LUMCON), found ... to be smaller than forecasted, measuring 3,000 square miles. However ... above the sea floor, was severe where it did occur, ... Earlier this summer, NOAA-sponsored forecast models developed by ...
... AUGUSTA, Ga. Distinctive patterns of genes turned ... cancerous cells could enable early screening for many common ... Georgia scientists say. Researchers are comparing chemical alterations, ... in healthy colon, breast, brain and lymphatic cells and ...
Cached Biology News:Researchers develop 'brain-reading' methods 2Researchers develop 'brain-reading' methods 3Researchers develop 'brain-reading' methods 4Smaller than expected, but severe, dead zone in Gulf of Mexico 2Cancer's distinctive pattern of gene expression could aid early screening and prevention 2Cancer's distinctive pattern of gene expression could aid early screening and prevention 3Cancer's distinctive pattern of gene expression could aid early screening and prevention 4
IgD Chain C (AMS 9.1)...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Applications: Epitope mapping, Mapping protein-protein contacts, Identification of enzyme substrates/inhibitors, Identification of receptor agonists/antagonists...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Biology Products: